RA CAPITAL MANAGEMENT, L.P.
Top Portfolio Positions
62 positions ·
$7,085,760,217 total
· as of Sep 30, 2025
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| ASND |
Ascendis Pharma A/S
Healthcare
|
10,281,496 | $2,044,064,219 | 28.85% | |
| RYTM |
Rhythm Pharmaceuticals, Inc.
Healthcare
|
5,681,359 | $573,760,445 | 8.10% | |
| PCVX |
Vaxcyte, Inc.
Healthcare
|
11,965,991 | $431,014,995 | 6.08% | |
| SION |
Sionna Therapeutics, Inc.
Healthcare
|
10,445,322 | $307,196,920 | 4.34% | |
| NAMS |
NewAmsterdam Pharma Co N.V.
Healthcare
|
10,138,938 | $288,351,396 | 4.07% | |
| MLYS |
Mineralys Therapeutics, Inc.
Healthcare
|
7,323,750 | $277,716,600 | 3.92% | |
| JANX |
Janux Therapeutics, Inc.
Healthcare
|
11,189,693 | $273,476,096 | 3.86% | |
| ACLX |
Arcellx, Inc.
Healthcare
|
3,036,527 | $249,298,866 | 3.52% | |
| LENZ |
LENZ Therapeutics, Inc.
Healthcare
|
4,178,823 | $194,649,575 | 2.75% | |
| TYRA |
Tyra Biosciences, Inc.
Healthcare
|
12,198,625 | $170,658,763 | 2.41% |
Portfolio Trend
23 quarters · across all stocks
Holdings in COAG
1 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-05-04 | $195,872,447 | 7,729,773 | Shares | Sole | 2026-05-11 | |
| No 13F history on record for this holder in this stock. | ||||||